Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Lennox, Belinda R; Tomei, Giuliano; Vincent, Sally-Anne; Yeeles, Ksenija; Pollard, Rebecca; Palmer-Cooper, Emma; Jones, Peter; Zandi, Michael S; Coles, Alasdair

View / Open Files

Accepted version (Microsoft Word, 69Kb)

Authors

Lennox, Belinda R

Tomei, Giuliano

Vincent, Sally-Anne

Yeeles, Ksenija

Pollard, Rebecca

Palmer-Cooper, Emma

Jones, Peter

Publication Date

2019-03

Journal Title

J Neurol Neurosurg Psychiatry

ISSN

0022-3050

Publisher

BMJ

Volume

Issue

Pages

365-367

Language

eng

Type

Article

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Lennox, B. R., Tomei, G., Vincent, S., Yeeles, K., Pollard, R., Palmer-Cooper, E., Jones, P., et al. (2019). Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).. J Neurol Neurosurg Psychiatry, 90 (3), 365-367. https://doi.org/10.1136/jnnp-2018-318124

Keywords

NMDA, neuroimmunology, schizophrenia, Adolescent, Adult, Antibodies, Feasibility Studies, Female, Humans, Immunoglobulins, Intravenous, Immunologic Factors, Immunotherapy, Male, Potassium Channels, Voltage-Gated, Psychotic Disorders, Receptors, GABA-A, Receptors, N-Methyl-D-Aspartate, Young Adult

Sponsorship

Stanley Medical Research Institute (SMRI) (14T-004)

Medical Research Council (MR/N019067/1)

Medical Research Council (MR/J012939/1)

Identifiers

External DOI: https://doi.org/10.1136/jnnp-2018-318124

This record's URL: https://www.repository.cam.ac.uk/handle/1810/283573

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.